Scientific Review of Hepatitis C Virus (HCV)
Primary Uses or Exposures: HCV is an RNA-enveloped virus. The major risk factor for infection is illegal intravenous drug use, which accounts for 60% of acute HCV infections in adults. Since the screening of blood and blood products for HCV began in the 1990s, blood transfusion has accounted for only a small percentage of adult HCV cases (about 3%). Other routes of transmission include sexual, perinatal (from mother to infant at birth), familial (at low rates), and through health-care practices, including transmission by contaminated equipment or supplies, from patient to patient (at low rates), and through occupational exposure (at low rates).
No Public Comments
- Review Group 1 Review Summary Document for Hepatitis C Virus (HCV) (November 13, 2002)
- Review Group 2 Review Summary Document for Hepatitis C Virus (HCV) (July 22, 2002)
- NTP Board of Scientific Counselors RoC Subcommittee Meeting (October 14, 2003)
Note on Accessibility: Persons with disabilities or using assistive technology may find some documents are not fully accessible. For assistance, contact Central Data Management or call 919-541-3419 and identify the documents/pages for which access is required. We will assist you in accessing the content of these files. NIEHS has helpful information on accessibility.